Back to CS Candriam S.C.A.
ADPT5 quarters
Position history for CSCandriam S.C.A.'s holdings in ADAPTIVE BIOTECHNOLOGIES
No. Candriam S.C.A. exited its ADPT (Adaptive Biotechnologies) position in Q2 2025. Its Q1 2025 13F listed 12,058 shares worth $89,591. Candriam S.C.A. first reported ADPT in Q3 2022 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$787,000
Total Shares Change
-110,493
Quarter-by-Quarter History
Other major holders of ADPT: VIKING GLOBAL INVESTORS LP